Guidance document : regulatory requirements for intravenous immunoglobulin products in Canada. : H13-9/27-2018E-PDF
"The purpose of this document is to provide guidance to sponsors of IVIG products on the regulatory requirements, particularly minimum clinical data requirements for submissions involving approved and non-approved IVIG products. This guidance applies to IVIG products which are: non-approved in Canada, approved but seeking to add indication(s) for use in Canada"--Introduction, page 5.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.862435&sl=1
| Ministère/Organisme | Canada. Health Canada. Canada. Health Products and Food Branch. |
|---|---|
| Titre | Guidance document : regulatory requirements for intravenous immunoglobulin products in Canada. |
| Variante du titre | Regulatory requirements for intravenous immunoglobulin products in Canada Regulatory requirements for IVIG products in Canada |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: Ligne directrice à l'intention des promoteurs : exigences réglementaires canadiennes applicables aux produits d'immunoglobuline intraveineuse. Cover title. "Publication date: October 2018." Issued by: Health Products and Food Branch. Issued also in HTML format. Includes bibliographical references. |
| Information sur la publication | Ottawa, ON : Health Canada = Santé Canada, 2018. ©2018 |
| Description | 1 online resource (12 pages) |
| ISBN | 9780660279435 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 180345 |
| Descripteurs | Health care products Health policy |